Janux Therapeutics, Inc. (JANX) has 32 open-market insider trades by 18 insiders since 2021. Over the last six months insiders net sold $86K. The most active filer is Jay Lichter, 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Jay Lichter | 10% Owner | — | 4 | $178.1M | 2024-09-13 |
| Avalon BioVentures SPV I, L.P. | 10% Owner | — | 1 | $129.7M | 2024-10-18 |
| Tighe Reardon | CFO | — | 3 | $103.6M | 2024-06-03 |
| Avalon Ventures XI, L.P. | 10% Owner | — | 2 | $79.9M | 2024-06-03 |
| Avalon BioVentures I, LP | 10% Owner | — | 3 | $65.0M | 2024-09-30 |
| Peter Kolchinsky | Dir10% Owner | — | 1 | $53.7M | 2024-10-18 |
| RA Capital Healthcare Fund LP | Dir10% Owner | — | 1 | $50.7M | 2025-06-11 |
| RA Capital Management, L.P. | Dir10% Owner | — | 1 | $50.0M | 2026-06-11 |
| Peter A. Thompson | Dir | — | 4 | $22.6M | 2021-12-29 |
| RA Capital Nexus Fund II, L.P. | Dir10% Owner | — | 1 | $12.3M | 2023-07-19 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Janeen Noel Doyle | — | Sell | $57K | 2026-06-02 |
| Maria Dobek | President & VP | Sell | $29K | 2026-05-11 |
| Thomas DiRaimondo | CSO | Sell | $34K | 2026-01-02 |
| Zachariah McIver | Chief Medical Officer | Sell | $37K | 2026-01-02 |
| Charles M. Winter | Chief Technical Officer | Sell | $33K | 2026-01-02 |
| David Alan Campbell | President | Sell | $111K |
Companies that share insiders with JANX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2026-01-02 |
| Andrew Hollman Meyer | Chief Business Officer | Sell | $26K | 2026-01-02 |
| Maria Dobek | President & Accounting | Sell | $20K | 2026-01-02 |
| Andrew Hollman Meyer | — | Sell | $110K | 2025-12-01 |
| Andrew Hollman Meyer | — | Sell | $100K | 2025-11-14 |
| Andrew Hollman Meyer | — | Sell | $1.0M | 2025-10-28 |
| Andrew Hollman Meyer | — | Sell | $200K | 2025-05-01 |
| Andrew Hollman Meyer | — | Sell | $100K | 2025-04-21 |
| RA Capital Healthcare Fund LP | Director & 10% Owner | Buy | $50.7M | 2025-03-05 |
| Andrew Hollman Meyer | — | Sell | $185K | 2025-03-03 |